Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease

Abstract The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson’s disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic m...

Full description

Bibliographic Details
Main Authors: Tereza Tykalova, Michal Novotny, Evzen Ruzicka, Petr Dusek, Jan Rusz
Format: Article
Language:English
Published: Nature Portfolio 2022-03-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-022-00286-y